Wei-wei Xiao
Overview
Explore the profile of Wei-wei Xiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Z, Xiao W, Li L, Wu X, Wang Q, Chang H, et al.
EClinicalMedicine
. 2024 Oct;
76:102836.
PMID: 39364270
Background: Neoadjuvant chemotherapy (NACT) is commonly used to downstage the tumor in locally advanced colon cancer (LACC) and improve the R0 resection rate. Neoadjuvant chemoradiotherapy (NACRT) is the standard treatment...
2.
Xiao W, Chen G, Gao Y, Lin J, Wu X, Luo H, et al.
Cancer Cell
. 2024 Aug;
42(9):1570-1581.e4.
PMID: 39094560
Neoadjuvant chemoradiotherapy (NACRT) was the standard treatment for patients with locally advanced rectal cancer (LARC) with proficient mismatch repair (pMMR) proteins. In this randomized phase 2 trial (ClinicalTrial.gov: NCT04304209), 134...
3.
Chen G, Jin Y, Guan W, Zhang R, Xiao W, Cai P, et al.
Lancet Gastroenterol Hepatol
. 2023 Mar;
8(5):422-431.
PMID: 36870360
Background: The current standard treatment for locally advanced rectal cancer is neoadjuvant chemoradiotherapy followed by radical surgery, but this approach can lead to multiple complications. We aimed to investigate the...
4.
Mei W, Wang X, Li Y, Sun Y, Yang C, Lin J, et al.
Ann Surg
. 2022 Dec;
277(4):557-564.
PMID: 36538627
Objective: To compare neoadjuvant chemotherapy (nCT) with CAPOX alone versus neoadjuvant chemoradiotherapy (nCRT) with capecitabine in locally advanced rectal cancer (LARC) with uninvolved mesorectal fascia (MRF). Background Data: nCRT is...
5.
Huang J, Chen S, Han N, Liu Z, Xiao W, Jiang B, et al.
Ann Transl Med
. 2022 Nov;
10(20):1131.
PMID: 36388784
Background: Since the first case reported in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an outbreak of coronavirus disease 2019 (COVID-19) worldwide. The global case...
6.
Wang Q, Zhang S, Xiao W, Zhou C, Chang H, Zeng Z, et al.
Radiat Oncol
. 2022 May;
17(1):98.
PMID: 35585551
Background: High dose chemoradiotherapy offers a curative chance for patients with rectal cancer that are unfit or unwilling to undergo surgical resection, yet its long-term survival and functional outcomes have...
7.
Han B, Yang X, Qu S, Guo Z, Huang L, Li K, et al.
Front Med (Lausanne)
. 2021 Dec;
8:684238.
PMID: 34926480
Cell-free DNA (cfDNA) serves as a footprint of the nucleosome occupancy status of transcription start sites (TSSs), and has been subject to wide development for use in noninvasive health monitoring...
8.
Yuan Y, Xie W, Li R, Chang H, Zeng Z, Gao Y, et al.
Cancer Med
. 2021 Nov;
11(1):117-127.
PMID: 34816622
Background: Anal squamous cell carcinoma (ASCC) is a rare malignant tumor with increasing incidence. The goal of our study was to analyze the treatment outcome and prognostic factors of ASCC...
9.
He F, Chen M, Xiao W, Zhang Q, Liu Y, Zheng J, et al.
Jpn J Clin Oncol
. 2021 Jun;
51(9):1391-1399.
PMID: 34155513
Background: The efficacy of the addition of neoadjuvant chemotherapy to neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer in elderly patients has not been established. Methods: A...
10.
Zhang S, Zhang R, Li R, Wang Q, Chang H, Ding P, et al.
Cancer Sci
. 2021 Jun;
112(9):3607-3615.
PMID: 34146368
This study aimed to identify patients who benefit from radical surgery among those with rectal cancer who achieved clinical complete response (cCR). Patients with locally advanced rectal cancer (LARC; stage...